Dapivirine Vaginal Ring Safe, Effective at Preventing HIV During Pregnancy
By Lori Solomon HealthDay Reporter
THURSDAY, March 14, 2024 -- Adverse pregnancy outcomes related to use of the dapivirine vaginal ring (DVR) or daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) during the second trimester are uncommon, according to a study presented at the annual Conference on Retroviruses and Opportunistic Infections, held from March 3 to 6 in Denver.
Felix Mhlanga, M.B.Ch.B., from the University of Zimbabwe in Harare, and colleagues presented results from the third cohort of women initiating the DVR product during the second trimester of pregnancy as part of a phase 3b study. The analysis included healthy, HIV-uninfected pregnant women (ages 18 to 40 years) from South Africa, Uganda, Zimbabwe, and Malawi who were randomly assigned (4:1) to monthly DVR (202 participants) or TDF/FTC (49 participants).
The researchers noted two stillbirths and one miscarriage. Most deliveries were at term (96 percent), and pregnancy complications were uncommon. In three cases in the DVR arm, preterm premature rupture of membranes occurred. Overall, 11 infant participants had congenital anomalies (most commonly umbilical hernias), none of which was related to the study product. No HIV infections occurred in this cohort of women.
"These data, combined with the data from cohorts 1 and 2 and the safety data from women who used the DVR at the time of conception, support using DVR and TDF/FTC as HIV prevention options for pregnant people at risk of HIV," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Neurobehavioral Issues Increased in Children With Prenatal Fluoride Exposure
TUESDAY, May 21, 2024 -- Prenatal fluoride exposure is associated with increased neurobehavioral problems, according to a study published online May 20 in JAMA Network...
Recommendations Developed for People With HIV Wanting to Breastfeed
MONDAY, May 20, 2024 -- In an American Academy of Pediatrics clinical report published online May 20 in Pediatrics, recommendations are presented for breastfeeding among people...
Cognitive Impairment Still Seen in Children, Teens With HIV
TUESDAY, April 30, 2024 -- Cognitive impairment persists in children and adolescents living with HIV even in the era of antiretroviral therapy (ART), according to research...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.